At a glance
ClinicalIndex Comparison RecordN/ACompleted· 158 enrolled
Drug / intervention
Self-removalprocedure
Likely dose
Not stated in record
Key inclusion· 3
- ✓Undergoing vaginal vault suspension or robot-assisted laparoscopic sacrocolpopexy for pelvic organ prolapse treatment
- ✓Failed voiding trial prior to discharge
- ✓May have concomitant procedures including hysterectomy, suburethral sling, anterior/posterior colporrhaphy, bilateral salpingectomy or salpingooophorectomy
Key exclusion· 2
- ✕Physical or mental impairment affecting ability to self-remove catheter (e.g., Multiple Sclerosis, Dementia, Parkinsonism, impaired mobility, wheelchair-bound)
- ✕Bladder injury, fistula repair, or other conditions requiring prolonged catheterization
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Is Self-discontinuation of a Transurethral Catheter Following Pelvic Reconstructive Surgery as Effective as Office-based Discontinuation?; A Randomized Controlled Trial
In Brief
A clinical study evaluating Self-removal for Postoperative Urinary Retention. Completed, enrolled 158 participants across 1 site.
Detailed Summary
This study is to determine if self-discontinuation of transurethral foley catheters in patients diagnosed with postoperative urinary retention (POUR), which is defined as the continued need for catheterization, following impatient pelvic organ prolapse surgery is non-inferior to office-discontinuation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Urinary Retention
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 2016
Enrollment StartJan 2017
Primary CompletionMay 2019
TodayJul 2026
First PostedDec 19, 2016
Enrollment StartJan 10, 2017
Primary CompletionMay 16, 2019
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 9.5 years ago
Interventions
Self-removalprocedure
Self-discontinuation of a transurethral catheter